Barclays adjusts Booking Holdings stock price target for stock split By Investing.com

Barclays cut Booking Holdings’ price target to $220 from $5,500 to reflect the company’s 25-for-1 stock split, while keeping an Overweight rating. The firm left gross booking value, revenue and EBITDA forecasts unchanged, with only share count, EPS and dividend per-share assumptions adjusted. The article also notes mixed analyst views across Booking and Expedia, including target increases and cuts tied to regional exposure, AI momentum and valuation.

Analysis

BKNG’s split-adjusted target reset is mechanically neutral, but the signaling matters: it reopens the stock to a broader retail and options audience while leaving operating assumptions intact. That tends to compress the gap between valuation support and momentum, because the market can re-anchor on the lower nominal share price even though intrinsic value is unchanged. The bigger second-order implication is for sentiment leadership in online travel: BKNG remains the quality benchmark, so any perceived upgrade in confidence can spill over to EXPE only if investors believe the demand cycle is broadening beyond premium international travel.

The divergence in analyst views is more important than the headline target changes. BKNG is being rewarded for execution durability and AI-related margin optics, while EXPE looks more vulnerable to geography mix and a less defensible product moat; that sets up a relative-value regime where BKNG can outperform even if the sector is flat. For banks, BCS/BAC are not direct reads here, but the broader takeaway is that capital returns and EPS optics are still powerful support factors in a market that is rewarding clean storylines over cyclical beta.

The contrarian risk is that the market overestimates how much a split changes demand for the stock. If the next 1-2 earnings prints fail to show a meaningful acceleration in booking growth or take-rate expansion, the post-split enthusiasm can fade quickly, especially if macro travel data softens into the shoulder season. On EXPE, the risk is that U.S. exposure becomes a headwind rather than a stabilizer if consumer spending rolls over; that would widen the multiple discount to BKNG over the next 1-3 quarters.

Key Decisions for Investors

• Long BKNG / short EXPE as a 3-6 month relative-value pair: BKNG has the cleaner execution narrative and stronger premium mix, while EXPE is more exposed to a domestic slowdown; target 8-12% spread widening, stop if EXPE guidance inflects upward or BKNG misses on bookings.
• Buy BKNG on post-split liquidity dislocations over the next 2-4 weeks, especially on weak open or index-driven selling; risk/reward favors owning the quality leader if options activity expands and retail participation lifts valuation support.
• Sell covered calls on EXPE into any relief rally over the next 1-2 months: implied upside looks capped unless management proves U.S. demand resilience, and the name is more likely to drift than rerate.
• Use BKNG versus a travel basket hedge rather than outright sector longs: the article supports idiosyncratic BKNG leadership, but not a broad travel re-rating, so pair exposure reduces macro beta.
• If BKNG fails to hold post-split momentum after the next earnings print, fade the move with short-dated call spreads or a tactical short into strength; the split itself is not a fundamental catalyst.